Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Clinical trial NCT07109336 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07109336
- Sponsor
- Zhongda Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-12-01
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.